Epidermal growth factor receptor status in stages of resected non-small cell lung cancer: Implications for treatment with epidermal growth factor receptor inhibitors

Analytical and Quantitative Cytology and Histology

Volumn 33, Issue 4, 2011, Pages 196-204

  Berardi, Rossana ^a   Santinelli, Alfredo ^b   Brunelli, Alessandro ^a   Onofri, Azzurra ^a   Pierantoni, Chiara ^a   Scartozzi, Mario ^a   Pisa, Eleonora ^b   Stramazzotti, Daniela ^b   Mazzanti, Paola ^a   Zuccatosta, Lina ^a   Gasparini, Stefano ^a   Sabbatini, Armando ^a   Cascinu, Stefano ^a  

^a Department of Medical Oncology ^*  (Italy)

^b Section of Pathological Anatomy and Histopathology   (Italy)

Author keywords

Epidermal growth factor receptor; Non small cell lung cancer; Prognostic factor; Targeted therapy

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL MEMBRANE; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT INDICATION; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 80955167959     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Van Raemdonck DE, Schneider A, Ginsberg RJ: Surgical treatment for higher stage non-small cell lung carcinoma. Ann Thorac Surg 1992;54:999-1013
2. Fu XL, Zhu XZ, Shi DR, Xiu LZ, Wang LJ, Zhao S, Qian H, Lu HF, Xiang YB, Jiang GL: Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 1999;23:143-152
3. Kanters SD, Lammers JW, Voest EE: Molecular and biological factors in the prognosis of non-small-cell lung cancer. Eur Respir J 1995;8:1389-1397
4. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP: Role of p53 as a prognostic factor for survival in lung cancer: A systematic review of the literature with a meta-analysis. Eur Respir J 2001;18:705-719
5. Huang SM, Harari PM: Epidermal growth factor receptor inhibition in cancer therapy: Biology, rationale and preliminary clinical results. Invest New Drugs 1999;17:259-269
6. Prenzel N, Fisher OM, Streit S, Hart S, Ullrich A: The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocri Relat Cancer 2001;8:11-31
7. Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E: Differential expression of the epidermal growth factor and its ligand in primary non-small cell lung cancers and adjacent benign lung. Cancer Res (10 Suppl) 1993;53:2379-2385
8. Kurie JM, Shin HJ, Lee JS, Morice RC, Ro JY, Lippman SM, Hittelman WN, Yu R, Lee JJ, Hong WK: Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin Cancer Res 1996;2:1787-1793
9. Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heim burger DC, Grizzle WE: Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res 2002;8:734-744
10. Scagliotti GV, Selvaggi G, Novello S, Hirsch FR: The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res 2004;10:4227-4232
11. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi H, Angeletti CA, Pingitore R, Pepe S, Basolo F, Bevilacqua G: Epidermal growth factor receptor (EGFr) expression in nonsmall cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer 1995;31A:178-183
12. Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, Salonga D, Hölscher AH, Danenberg PV: Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res 2001;7:1850-1855
13. Pastorino U, Andreola S, Tagliabue E, Pezzella F, Incarbone M, Sozzi G, Buyse M, Menard S, Pierotti M, Rilke F: Immunohistochemical markers in stage I lung cancer: Relevance to prognosis. J Clin Oncol 1997;15:2858-2865
14. Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E: Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 1997;3:515-522
15. Volm M, Dring P, Wodrich W: Prognostic significance of the expression of c-fos, c-jun, and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol 1993;119:507-510
16. Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL: Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 1987;55:513-516
17. Fontanini G, De Laurentiis M, Vignati S, Chinè S, Lucchi M, Silvestri V, Mussi A, De Placido S, Tortora G, Bianco AR, Gullick W, Angeletti CA, Bevilacqua G, Ciardiello F: Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res 1998;4:241-249
18. Ohsaki Y, Tanno S, Fujita Y, Toyoshima E, Fujiuchi S, Nishigaki Y, Ishida S, Nagase A, Miyokawa N, Hirata S, Kikuchi K: Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep 2000;7:603-607
19. Reinmuth N, Brandt B, Kunze WP, Junker K, Thomas M, Achatzy R, Scheld HH, Semik M: Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2, erbB3 in non-small cell lung cancer. Eur Respir J 2000;16:991-996
20. Veale D, Kerr N, Gibson GJ, Kelly PJ, Harris AL: The relationship of quantitative epidermal growth factor receptor expression in non-small-cell lung cancer to long term survival. Br J Cancer 1993;68:162-165
21. D'Amico TA, Massey M, Herndon JE 2nd, Moore MB, Harpole DH Jr: A biological risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 1999;117:736-743
22. Meert AP, Martin B, Delmotte P, Berghmans T, Lafitte JJ, Mascaux C, Paesmans M, Steels E, Verdebout JM, Sculier JP: The role of EGF-R expression on patient survival in lung cancer: A systematic review with meta-analysis. Eur Respir J 2002;20:975-981
23. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K: Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: A metaanalysis. Thorax 2006;61:140-145
24. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717
25. Nicholson RI, Gee JM, Harper ME: EGFR and cancer prognosis. Eur J Cancer 2001;37:S9-S15
26. Selvaggi G, Novello S, Torri V, Leonardo E, De Giuli P, Borasio P, Mossetti C, Ardissone F, Lausi P, Scagliotti GV: Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann Oncol 2004;15:28-32
27. Ludovini V, Bellezza G, Pistola L, Bianconi F, Di Carlo L, Sidoni A, Semeraro A, Del Sordo R, Tofanetti FR, Mameli MG, Daddi G, Cavaliere A, Tonato M, Crinò L: High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-smallcell lung cancer patients. Ann Oncol 2009;20:842-849
28. Berghmans T, Mascaux C, Haller A, Meert AP, Van Houtte P, Sculier JP: EGFR, TTF-1 and Mdm2 expression in stage III non-small cell lung cancer: A positive association. Lung Cancer 2008;62:35-44
29. Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A, Tonato M, Franklin WA, Crino L, Bunn PA Jr, Varella-Garcia M: Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small cell lung cancer. J Natl Cancer Inst 2005;97:643-655
30. Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA: Erlotinib in lung cancer: Molecular and clinical predictors of outcome. N Engl J Med 2005;353:133-144